BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Am J Transplant 2019;19:1708-19. [PMID: 30414349 DOI: 10.1111/ajt.15177] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee BT, Fiel MI, Schiano TD. Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective. J Hepatol 2021:S0168-8278(21)01957-7. [PMID: 34343613 DOI: 10.1016/j.jhep.2021.07.027] [Reference Citation Analysis]
2 Mannon RB, Morris RE, Abecassis M, Axelrod D, Bala S, Friedman GS, Heeger PS, Lentine KL, Loupy A, Murphy B, Nickerson P, Sarwal M, O'Doherty I, Spear N, Karpen SR. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report. Am J Transplant 2020;20:1495-502. [PMID: 32090461 DOI: 10.1111/ajt.15833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Sureshkumar KK, Chopra B. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation. Transplant Proc 2019;51:1796-800. [PMID: 31399165 DOI: 10.1016/j.transproceed.2019.04.059] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Krummey SM, Bray RA, Gebel HM, Sullivan HC. Eplet mismatch imputation studies should include immunologic risk assessment. Am J Transplant 2021. [PMID: 33728758 DOI: 10.1111/ajt.16562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wiebe C, Nickerson PW. Molecular Mismatch-the Renaissance of HLA in Kidney Transplantation. J Am Soc Nephrol 2020;31:1922-5. [PMID: 32868374 DOI: 10.1681/ASN.2020071011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Nickerson PW. What have we learned about how to prevent and treat antibody‐mediated rejection in kidney transplantation? Am J Transplant 2020;20:12-22. [DOI: 10.1111/ajt.15859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Brunker PAR, Pattanayak V, Mahowald GK. Finding platelets: Don't let the perfect be the enemy of the good. Transfusion 2021;61:2223-8. [PMID: 34365668 DOI: 10.1111/trf.16586] [Reference Citation Analysis]
8 Senev A, Coemans M, Lerut E, Van Sandt V, Kerkhofs J, Daniëls L, Driessche MV, Compernolle V, Sprangers B, Van Loon E, Callemeyn J, Claas F, Tambur AR, Verbeke G, Kuypers D, Emonds MP, Naesens M. Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study. J Am Soc Nephrol 2020;31:2193-204. [PMID: 32764139 DOI: 10.1681/ASN.2020010019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
9 Charnaya O, Jones J, Philogene MC, Chiang PY, Segev DL, Massie AB, Garonzik-Wang J. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients. Pediatr Nephrol 2021. [PMID: 34100108 DOI: 10.1007/s00467-021-05078-9] [Reference Citation Analysis]
10 Sakamoto S, Iwasaki K, Tomosugi T, Niemann M, Spierings E, Miwa Y, Horimi K, Takeda A, Goto N, Narumi S, Watarai Y, Kobayashi T. Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study. Front Immunol 2020;11:2000. [PMID: 32973806 DOI: 10.3389/fimmu.2020.02000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Krummey SM, Cliff Sullivan H. The utility of imputation for molecular mismatch analysis in solid organ transplantation. Hum Immunol 2022:S0198-8859(21)00280-9. [PMID: 35216846 DOI: 10.1016/j.humimm.2021.11.008] [Reference Citation Analysis]
12 Hart A, Singh D, Brown SJ, Wang JH, Kasiske BL. Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: A systematic review. Clin Transplant 2021;35:e14320. [PMID: 33864724 DOI: 10.1111/ctr.14320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Habal MV. Current Desensitization Strategies in Heart Transplantation. Front Immunol 2021;12:702186. [PMID: 34504489 DOI: 10.3389/fimmu.2021.702186] [Reference Citation Analysis]
14 Kramer CSM, Franke-van Dijk MEI, Bakker KH, Uyar-Mercankaya M, Karahan GE, Roelen DL, Claas FHJ, Heidt S. Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR. Am J Transplant 2020;20:3341-53. [PMID: 32342632 DOI: 10.1111/ajt.15950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Engen RM, Jedraszko AM, Conciatori MA, Tambur AR. Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in transplantation. Am J Transplant 2021;21:344-52. [PMID: 32430947 DOI: 10.1111/ajt.16070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
16 Nickerson PW, Balshaw R, Wiebe C, Ho J, Gibson IW, Bridges ND, Rush DN, Heeger PS. A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation. Am J Transplant 2021;21:1503-12. [PMID: 32956576 DOI: 10.1111/ajt.16311] [Reference Citation Analysis]
17 Yin Y, Butler C, Zhang Q. Challenges in the application of NGS in the clinical laboratory. Hum Immunol 2021:S0198-8859(21)00083-5. [PMID: 33892986 DOI: 10.1016/j.humimm.2021.03.011] [Reference Citation Analysis]
18 Wiebe C, Nickerson PW. Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients. Current Opinion in Organ Transplantation 2020;25:8-14. [DOI: 10.1097/mot.0000000000000714] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
19 Zahran S, Bourdiec A, Zhang X, Sapir-Pichhadze R. Not all eplet mismatches are created equal - A cohort study illustrating implications to long-term graft outcomes. Hum Immunol 2021:S0198-8859(21)00260-3. [PMID: 34844785 DOI: 10.1016/j.humimm.2021.11.007] [Reference Citation Analysis]
20 Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Am J Transplant 2019;19:1708-19. [PMID: 30414349 DOI: 10.1111/ajt.15177] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
21 Cruz TD, Dames C, Pagaduan L, Cho Y, Kong D, Rajalingam R. Concurrent use of two independent methods prevents erroneous HLA typing of deceased organ donors – An important strategy for patient safety and accurate virtual crossmatching for broader sharing. Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.02.004] [Reference Citation Analysis]
22 Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
23 Schawalder L, Hönger G, Kleiser M, van Heck MR, van de Pasch LAL, Vendelbosch S, Rozemuller EH, Schaub S. Development of an immunogenicity score for HLA-DQ eplets: A conceptual study. HLA 2021;97:30-43. [PMID: 33068062 DOI: 10.1111/tan.14110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Li X, Wei Y, Li J, Deng R, Fu Q, Nie W, Zhang H, Wu C, Su X, Wang J, Cao D, Liu X, Liu L, Wang C. Donor HLA genotyping of ex vivo expanded urine cells from kidney transplant recipients. HLA 2021;98:431-47. [PMID: 34505410 DOI: 10.1111/tan.14426] [Reference Citation Analysis]
25 Wiebe C, Nickerson PW. Role of HLA molecular mismatch in clinical practice. Hum Immunol 2021:S0198-8859(21)00258-5. [PMID: 34887099 DOI: 10.1016/j.humimm.2021.11.005] [Reference Citation Analysis]
26 Shieh M, Hayeck TJ, Dinh A, Duke JL, Chitnis N, Mosbruger T, Morlen RP, Ferriola D, Kneib C, Hu T, Huang Y, Monos DS. Complex Linkage Disequilibrium Effects in HLA-DPB1 Expression and Molecular Mismatch Analyses of Transplantation Outcomes. Transplantation 2021;105:637-47. [PMID: 32301906 DOI: 10.1097/TP.0000000000003272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Shin S, Lee M, Dente E, Yazigi N, Khan KM, Kaufman SS, Ahn J, Timofeeva OA, Ekong UD. Mismatch epitope load predicts de novo‐DSA‐free survival in pediatric liver transplantation. Pediatric Transplantation. [DOI: 10.1111/petr.14251] [Reference Citation Analysis]
28 Mohammadhassanzadeh H, Oualkacha K, Zhang W, Klement W, Bourdiec A, Lamsatfi J, Yi Y, Foster B, Keown P, Gebel HM, Claas F, Sapir-Pichhadze R; Genome Canada Transplant Consortium. On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss. Kidney Int Rep 2021;6:1567-79. [PMID: 34169197 DOI: 10.1016/j.ekir.2021.03.877] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Johnson AC, Zhang J, Cliff Sullivan H, Wiebe C, Bray R, Gebel H, Larsen CP. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients. Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.01.007] [Reference Citation Analysis]
30 Hart A, Schladt DP, Matas AJ, Itzler R, Israni AK, Kasiske BL. Incidence, risk factors, and long-term outcomes associated with antibody-mediated rejection - The long-term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study. Clin Transplant 2021;35:e14337. [PMID: 33955070 DOI: 10.1111/ctr.14337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 San Segundo D, Guiral-Foz SA, Benito-Hernández A, Fernández AR, Arnau A, Valero R, Ramos-Barrón MA, García-Unzueta MT, Gómez-Ortega JM, López-Hoyos M, Ruiz JC, Rodrigo E. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients. Transpl Immunol 2021;70:101494. [PMID: 34774739 DOI: 10.1016/j.trim.2021.101494] [Reference Citation Analysis]
32 Wiebe C, Nickerson PW. More precise donor–recipient matching: the role of eplet matching. Current Opinion in Nephrology & Hypertension 2020;29:630-5. [DOI: 10.1097/mnh.0000000000000649] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Tambur AR, Campbell P, Chong AS, Feng S, Ford ML, Gebel H, Gill RG, Kelsoe G, Kosmoliaptsis V, Mannon RB, Mengel M, Reed EF, Valenzuela NM, Wiebe C, Dijke IE, Sullivan HC, Nickerson P. Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. Am J Transplant 2020;20:2652-68. [PMID: 32342639 DOI: 10.1111/ajt.15937] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
34 Kotecha S, Ivulich S, Snell G. Review: immunosuppression for the lung transplant patient. J Thorac Dis 2021;13:6628-44. [PMID: 34992841 DOI: 10.21037/jtd-2021-11] [Reference Citation Analysis]
35 Davis S, Wiebe C, Campbell K, Anobile C, Aubrey M, Stites E, Grafals M, Pomfret E, Nickerson P, Cooper JE. Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort. Am J Transplant 2021;21:322-8. [PMID: 32888256 DOI: 10.1111/ajt.16290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Pullen LC. Discarding Kidneys-Can We Do Better? Am J Transplant 2019;19:3215-6. [PMID: 31778008 DOI: 10.1111/ajt.15693] [Reference Citation Analysis]
37 Guiral S, Segundo DS, Irure J, Casafont F, Fortea JI, Puente Á, López-hoyos M, Crespo J, Fabrega E. Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell–Mediated Rejection After Liver Transplantation. Transplantation 2020;104:562-7. [DOI: 10.1097/tp.0000000000002921] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Reindl-Schwaighofer R, Heinzel A, Gualdoni GA, Mesnard L, Claas FHJ, Oberbauer R. Novel insights into non-HLA alloimmunity in kidney transplantation. Transpl Int 2020;33:5-17. [PMID: 31650645 DOI: 10.1111/tri.13546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
39 Wood-Trageser MA, Xu Q, Zeevi A, Randhawa P, Lesniak D, Demetris AJ. Precision transplant pathology. Curr Opin Organ Transplant 2020;25:412-9. [PMID: 32520786 DOI: 10.1097/MOT.0000000000000772] [Reference Citation Analysis]
40 Issa F, Strober S, Leventhal JR, Kawai T, Kaufman DB, Levitsky J, Sykes M, Mas V, Wood KJ, Bridges N, Welniak LA, Chandran S, Madsen JC, Nickerson P, Demetris AJ, Lakkis FG, Thomson AW. The Fourth International Workshop on Clinical Transplant Tolerance. Am J Transplant 2021;21:21-31. [PMID: 32529725 DOI: 10.1111/ajt.16139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
41 Sypek MP, Hughes P. HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up. Kidney Int Rep 2021;6:1500-2. [PMID: 34169190 DOI: 10.1016/j.ekir.2021.04.027] [Reference Citation Analysis]
42 Meneghini M, Crespo E, Niemann M, Torija A, Lloberas N, Pernin V, Fontova P, Melilli E, Favà A, Montero N, Manonelles A, Cruzado JM, Palou E, Martorell J, Grinyó JM, Bestard O. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation. Front Immunol 2020;11:623276. [PMID: 33776988 DOI: 10.3389/fimmu.2020.623276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Tambur AR, Kosmoliaptsis V, Claas FHJ, Mannon RB, Nickerson P, Naesens M. Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen matching priorities to improve transplant outcomes? An expert review and recommendations. Kidney Int 2021:S0085-2538(21)00657-8. [PMID: 34246656 DOI: 10.1016/j.kint.2021.06.026] [Reference Citation Analysis]
44 Dreyer GJ, de Fijter JW. Transplanting the Elderly: Mandatory Age- and Minimal Histocompatibility Matching. Front Immunol 2020;11:359. [PMID: 32226428 DOI: 10.3389/fimmu.2020.00359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
45 Wen J, Basu A, Bentall A, Henderson N, Dukek B, Gandhi M, Schinstock C. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody? Hum Immunol 2021;82:240-6. [PMID: 33618904 DOI: 10.1016/j.humimm.2021.02.004] [Reference Citation Analysis]
46 Kumar V, Locke JE. New Perspectives on Desensitization in the Current Era - An Overview. Front Immunol 2021;12:696467. [PMID: 34394089 DOI: 10.3389/fimmu.2021.696467] [Reference Citation Analysis]
47 Kong D, Lee N, Dela Cruz ID, Dames C, Maruthamuthu S, Golden T, Rajalingam R. Concurrent typing of over 4000 samples by long-range PCR amplicon-based NGS and rSSO revealed the need to verify NGS typing for HLA allelic dropouts. Hum Immunol 2021;82:581-7. [PMID: 33980471 DOI: 10.1016/j.humimm.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ono K, Ide K, Tanaka Y, Ohira M, Tahara H, Tanimine N, Yamane H, Ohdan H. Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation. Liver Transpl 2021. [PMID: 34310028 DOI: 10.1002/lt.26238] [Reference Citation Analysis]
49 Mayer KA, Doberer K, Eskandary F, Halloran PF, Böhmig GA. New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment. Curr Opin Organ Transplant 2021;26:97-105. [PMID: 33315763 DOI: 10.1097/MOT.0000000000000832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Jackson AM, Pinelli DF. Understanding the impact of HLA molecular mismatch in solid organ transplantation: Are we there yet? Am J Transplant 2021;21:9-10. [PMID: 33107168 DOI: 10.1111/ajt.16376] [Reference Citation Analysis]
51 Shaw BI, Villani V, Kesseli SJ, Nobuhara C, Samoylova ML, Moris D, Collins BH, McElroy LM, Poh M, Knechtle SJ, Barbas AS, Seigler HF. A Historical Cohort in Kidney Transplantation: 55-Year Follow-Up of 72 HLA-Identical, Donor-Recipient Pairs. J Clin Med 2021;10:5505. [PMID: 34884207 DOI: 10.3390/jcm10235505] [Reference Citation Analysis]
52 Saleem N, Das R, Tambur AR. Molecular histocompatibility beyond Tears: The next generation version. Human Immunology 2022. [DOI: 10.1016/j.humimm.2021.12.005] [Reference Citation Analysis]
53 Philogene MC, Amin A, Zhou S, Charnaya O, Vega R, Desai N, Neu AM, Pruette CS. Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis. Pediatr Nephrol 2020;35:719. [PMID: 31828470 DOI: 10.1007/s00467-019-04444-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Wiebe C, Rush DN, Gibson IW, Pochinco D, Birk PE, Goldberg A, Blydt-Hansen T, Karpinski M, Shaw J, Ho J, Nickerson PW. Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection. Am J Transplant 2020;20:2499-508. [PMID: 32185878 DOI: 10.1111/ajt.15860] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
55 Bloom RD, Augustine JJ. Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34362810 DOI: 10.2215/CJN.14840920] [Reference Citation Analysis]
56 Hernández D, Vázquez T, Alonso-Titos J, León M, Caballero A, Cobo MA, Sola E, López V, Ruiz-Esteban P, Cruzado JM, Sellarés J, Moreso F, Manonelles A, Torio A, Cabello M, Delgado-Burgos J, Casas C, Gutiérrez E, Jironda C, Kanter J, Serón D, Torres A. Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients. J Clin Med 2021;10:1934. [PMID: 33947168 DOI: 10.3390/jcm10091934] [Reference Citation Analysis]
57 Miyairi S, Baldwin WM 3rd, Valujskikh A, Fairchild RL. Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts. Transplantation 2021;105:284-90. [PMID: 32384380 DOI: 10.1097/TP.0000000000003298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Bedford A, Jervis S, Worthington J, Lowe M, Poulton K. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation. Int J Immunogenet 2021. [PMID: 34904369 DOI: 10.1111/iji.12563] [Reference Citation Analysis]
59 Böhmig GA, Eskandary F, Doberer K, Halloran PF. The therapeutic challenge of late antibody-mediated kidney allograft rejection. Transpl Int 2019;32:775-88. [PMID: 30955215 DOI: 10.1111/tri.13436] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
60 Lemieux W, Mohammadhassanzadeh H, Klement W, Daniel C, Sapir-Pichhadze R. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation. Int J Immunogenet 2021;48:135-44. [PMID: 33426788 DOI: 10.1111/iji.12525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Yeung MY. Histocompatibility Assessment in Precision Medicine for Transplantation: Towards a Better Match. Seminars in Nephrology 2022;42:44-62. [DOI: 10.1016/j.semnephrol.2022.01.004] [Reference Citation Analysis]
62 Rampersad C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, Goldberg A, Birk P, Rush DN, Nickerson PW, Wiebe C. The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant 2021. [PMID: 34717048 DOI: 10.1111/ajt.16883] [Reference Citation Analysis]
63 Montgomery MC, Liu C, Petraroia R, Weimer ET. Using Nanopore Whole-Transcriptome Sequencing for Human Leukocyte Antigen Genotyping and Correlating Donor Human Leukocyte Antigen Expression with Flow Cytometric Crossmatch Results. The Journal of Molecular Diagnostics 2020;22:101-10. [DOI: 10.1016/j.jmoldx.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
64 Bezstarosti S, Kramer CSM, Claas FHJ, de Fijter JW, Reinders MEJ, Heidt S. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes. Hum Immunol 2021:S0198-8859(21)00292-5. [PMID: 34963506 DOI: 10.1016/j.humimm.2021.12.002] [Reference Citation Analysis]